Sign InGet Access
← All deals

ILLUMINA, INC.

Public Equity (Nasdaq Stock Market)BiotechnologyGenomicsPublic Company
📍 San Diego, CA, United States• Founded 1998• 8625 employees
🌐 Websitein LinkedIn
StreetZero Signal 73
Be the first to signal interest

About ILLUMINA, INC.

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables for genetic analysis. It is a public company headquartered in San Diego, CA, founded in 1998, with 8,625 employees.

LATEST FUNDINGRule 144
$87.2M
Announced 2026-11-03
TOTAL RAISED1.87B USD
🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for ILLUMINA, INC..

Create free accountSign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS
EMPLOYEES8625
FOUNDED1998
HQSan Diego, CA, United States
Industry
Public Equity (Nasdaq Stock Market)
Tags
BiotechnologyGenomicsPublic CompanyHealthcare

Investors

Bank of AmericaARCH Venture PartnersVenrockState Farm

Key highlights

  • Public company on Nasdaq under ticker ILMN with market cap over $38B.
  • Provides sequencing instruments and consumables for genetic analysis worldwide.
  • Completed $87.2M Rule 144 private placement in San Diego, CA.
  • Employs 8,625 people and maintains broad institutional ownership.

Ask StreetZero about ILLUMINA, INC.

Put our AI to work on this deal.

What is ILLUMINA, INC.'s value proposition?Who are ILLUMINA, INC.'s competitors?Why does this raise matter?Summarize ILLUMINA, INC. for an investor.

Similar companies

Other Public Equity (Nasdaq Stock Market) deals, ranked by Signal.

Alamar Biosciences, Inc.
$36.7M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account